Alan Dunton

Alan Dunton

Directeur/Bestuurslid bij CORMEDIX INC.

Vermogen: 595 501 $ op 31-05-2026

71 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Dr. Alan W.
Dunton
, MD, is an Independent Non-Executive Director at Recce Pharmaceuticals Ltd., an Independent Director at CorMedix, Inc., an Independent Director at Palatin Technologies, Inc. and an Independent Director at Oragenics, Inc. He is on the Board of Directors at Recce Pharmaceuticals Ltd., CorMedix, Inc., Cytogel Pharma LLC, Palatin Technologies, Inc., Oragenics, Inc. and ActivBiotics, Inc. Dr. Dunton was previously employed as an Independent Non-Executive Director by Regeneus Ltd., a SVP-Regulatory Affairs, Research & Development by Purdue Pharma LP, a Non-Executive Director by Bionomics Ltd., a Chief Medical Officer by Derma Sciences, Inc., a Non-Executive Chairman by EpiCept Corp., a Chief Medical Officer by Marina Biotech, Inc., a Managing Director by Panacos Pharmaceuticals, Inc., an Independent Director by Targacept, Inc., a Principal Owner by Danerius LLC, a President & Chief Executive Officer by Metaphore Pharmaceuticals, Inc., a President, Chief Operating Officer & Director by Emisphere Technologies, Inc., a President & Managing Director by The Janssen Research Foundation, a Senior Executive by Johnson & Johnson, a Vice President-Clinical Research & Development by Syntex Corp., a Vice President-Clinical Research & Development by Ciba-Geigy Corp., a Vice President-Clinical Research & Development by Hoffmann-La Roche, Inc., a Chairman by Janssen-Cilag International NV, He received his undergraduate degree from State University of New York at Buffalo and a doctorate degree from New York University School of Medicine.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
13-04-2026 40.250 ( 0,05% ) 339 710 $ 31-05-2026
09-12-2025 14.081 ( 0,79% ) 197 416 $ 31-05-2026
30-06-2025 146.288 ( 0,05% ) 57 889 $ 31-05-2026
30-04-2026 802 ( 0,02% ) 486 $ 31-05-2026

Actieve functies van Alan Dunton

BedrijvenFunctieBegin
CORMEDIX INC. Directeur/Bestuurslid 01-03-2019
ORAGENICS, INC. Directeur/Bestuurslid 01-04-2011
PALATIN TECHNOLOGIES, INC. Directeur/Bestuurslid 22-06-2011
RECCE PHARMACEUTICALS LTD Directeur/Bestuurslid 14-07-2020
Directeur/Bestuurslid 01-10-2018
Directeur/Bestuurslid 01-01-2007

Eerdere bekende functies van Alan Dunton

BedrijvenFunctieEinde
REGENEUS LTD Directeur/Bestuurslid 25-02-2021
Hoofd Techniek/Wetenschap/O&O 01-03-2018
ADHERA THERAPEUTICS, INC. Hoofd Techniek/Wetenschap/O&O 21-02-2017
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Alan Dunton in detail bekijken

Opleiding van Alan Dunton

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

71

Eerstegraads connecties

34

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

Health Technology

The Janssen Research Foundation

R.W. Johnson Pharmaceutical Research Institute

Danerius LLC

Commercial Services

Johnson & Johnson Pharmaceutical Group

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Alan Dunton
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU